2018-2025 Microbiome Drugs Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

Table of Contents

2018-2025 Microbiome Drugs Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

1 Industry Overview of Microbiome Drugs

• 1.1 Microbiome Drugs Market Overview
  • 1.1.1 Microbiome Drugs Product Scope
  • 1.1.2 Market Status and Outlook
• 1.2 Global Microbiome Drugs Market Size and Analysis by Regions
  • 1.2.1 United States
  • 1.2.2 EU
  • 1.2.3 Japan
  • 1.2.4 China
  • 1.2.5 India
  • 1.2.6 Southeast Asia
• 1.3 Microbiome Drugs Market by Type
  • 1.3.1 Probiotics
  • 1.3.2 Prebiotics
  • 1.3.3 Small Molecules
  • 1.3.4 Biological Drugs
  • 1.3.5 Other
• 1.4 Microbiome Drugs Market by End Users/Application
  • 1.4.1 Hospital Pharmacies
  • 1.4.2 Retail Pharmacies
  • 1.4.3 Online Pharmacies
  • 1.4.4 Other

2 Global Microbiome Drugs Competition Analysis by Players

• 2.1 Microbiome Drugs Market Size (Value) by Players (2017 and 2018)
• 2.2 Competitive Status and Trend
  • 2.2.1 Market Concentration Rate
  • 2.2.2 Product/Service Differences
  • 2.2.3 New Entrants
  • 2.2.4 The Technology Trends in Future

3 Company (Top Players) Profiles

• 3.1 Pfizer
  • 3.1.1 Company Profile
  • 3.1.2 Main Business/Business Overview
  • 3.1.3 Products, Services and Solutions
  • 3.1.4 Microbiome Drugs Revenue (Value) (2013-2018)
  • 3.1.5 Recent Developments
• 3.2 Second Genome
  • 3.2.1 Company Profile
  • 3.2.2 Main Business/Business Overview
  • 3.2.3 Products, Services and Solutions
  • 3.2.4 Microbiome Drugs Revenue (Value) (2013-2018)
  • 3.2.5 Recent Developments
• 3.3 Seres Therapeutics
  • 3.3.1 Company Profile
  • 3.3.2 Main Business/Business Overview
  • 3.3.3 Products, Services and Solutions
  • 3.3.4 Microbiome Drugs Revenue (Value) (2013-2018)
  • 3.3.5 Recent Developments
• 3.4 MaaT Pharma
  • 3.4.1 Company Profile
  • 3.4.2 Main Business/Business Overview
  • 3.4.3 Products, Services and Solutions
  • 3.4.4 Microbiome Drugs Revenue (Value) (2013-2018)
  • 3.4.5 Recent Developments
• 3.5 Enterome Bioscience
  • 3.5.1 Company Profile
  • 3.5.2 Main Business/Business Overview
  • 3.5.3 Products, Services and Solutions
  • 3.5.4 Microbiome Drugs Revenue (Value) (2013-2018)
  • 3.5.5 Recent Developments
• 3.6 MicroBiome Therapeutics
  • 3.6.1 Company Profile
  • 3.6.2 Main Business/Business Overview
  • 3.6.3 Products, Services and Solutions
  • 3.6.4 Microbiome Drugs Revenue (Value) (2013-2018)
  • 3.6.5 Recent Developments
• 3.7 Ritter Pharmaceuticals
  • 3.7.1 Company Profile
  • 3.7.2 Main Business/Business Overview
  • 3.7.3 Products, Services and Solutions
  • 3.7.4 Microbiome Drugs Revenue (Value) (2013-2018)
  • 3.7.5 Recent Developments
• 3.8 Rebiotix
  • 3.8.1 Company Profile
  • 3.8.2 Main Business/Business Overview
  • 3.8.3 Products, Services and Solutions
  • 3.8.4 Microbiome Drugs Revenue (Value) (2013-2018)
  • 3.8.5 Recent Developments
• 3.9 OpenBiome
  • 3.9.1 Company Profile
  • 3.9.2 Main Business/Business Overview
  • 3.9.3 Products, Services and Solutions
  • 3.9.4 Microbiome Drugs Revenue (Value) (2013-2018)
  • 3.9.5 Recent Developments

4 Global Microbiome Drugs Market Size by Type and Application (2013-2018)

• 4.1 Global Microbiome Drugs Market Size by Type (2013-2018)
• 4.2 Global Microbiome Drugs Market Size by Application (2013-2018)
• 4.3 Potential Application of Microbiome Drugs in Future
• 4.4 Top Consumer/End Users of Microbiome Drugs

5 United States Microbiome Drugs Development Status and Outlook

• 5.1 United States Microbiome Drugs Market Size (2013-2018)
• 5.2 United States Microbiome Drugs Market Size and Market Share by Players (2017 and 2018)

6 EU Microbiome Drugs Development Status and Outlook

• 6.1 EU Microbiome Drugs Market Size (2013-2018)
• 6.2 EU Microbiome Drugs Market Size and Market Share by Players (2017 and 2018)

7 Japan Microbiome Drugs Development Status and Outlook

• 7.1 Japan Microbiome Drugs Market Size (2013-2018)
• 7.2 Japan Microbiome Drugs Market Size and Market Share by Players (2017 and 2018)

8 China Microbiome Drugs Development Status and Outlook

• 8.1 China Microbiome Drugs Market Size (2013-2018)
• 8.2 China Microbiome Drugs Market Size and Market Share by Players (2017 and 2018)

9 India Microbiome Drugs Development Status and Outlook

• 9.1 India Microbiome Drugs Market Size (2013-2018)
• 9.2 India Microbiome Drugs Market Size and Market Share by Players (2017 and 2018)

10 Southeast Asia Microbiome Drugs Development Status and Outlook

• 10.1 Southeast Asia Microbiome Drugs Market Size (2013-2018)
• 10.2 Southeast Asia Microbiome Drugs Market Size and Market Share by Players (2017 and 2018)

11 Market Forecast by Regions, Type and Application (2018-2025)

• 11.1 Global Microbiome Drugs Market Size (Value) by Regions (2018-2025)
  • 11.1.1 United States Microbiome Drugs Revenue and Growth Rate (2018-2025)
  • 11.1.2 EU Microbiome Drugs Revenue and Growth Rate (2018-2025)
  • 11.1.3 Japan Microbiome Drugs Revenue and Growth Rate (2018-2025)
  • 11.1.4 China Microbiome Drugs Revenue and Growth Rate (2018-2025)
  • 11.1.5 India Microbiome Drugs Revenue and Growth Rate (2018-2025)
  • 11.1.6 Southeast Asia Microbiome Drugs Revenue and Growth Rate (2018-2025)
• 11.2 Global Microbiome Drugs Market Size (Value) by Type (2018-2025)
• 11.3 Global Microbiome Drugs Market Size by Application (2018-2025)

12 Microbiome Drugs Market Dynamics

• 12.1 Microbiome Drugs Market Opportunities
• 12.2 Microbiome Drugs Challenge and Risk
  • 12.2.1 Competition from Opponents
  • 12.2.2 Downside Risks of Economy
• 12.3 Microbiome Drugs Market Constraints and Threat
  • 12.3.1 Threat from Substitute
  • 12.3.2 Government Policy
  • 12.3.3 Technology Risks
• 12.4 Microbiome Drugs Market Driving Force
  • 12.4.1 Growing Demand from Emerging Markets
  • 12.4.2 Potential Application

13 Market Effect Factors Analysis

• 13.1 Technology Progress/Risk
  • 13.1.1 Substitutes
  • 13.1.2 Technology Progress in Related Industry
• 13.2 Consumer Needs Trend/Customer Preference
• 13.3 External Environmental Change
  • 13.3.1 Economic Fluctuations
  • 13.3.2 Other Risk Factors

14 Research Finding/Conclusion

15 Appendix

Methodology

Analyst Introduction

Data Source